CAS: 406-87-1; 4,4,4-Trifluorobutanal

该化合物是一种含分子式C4H5F3O的氟己烷.该化合物的特征是,接近甲醛功能的三氟甲基组,增强了其在有机合成中的活性和应用性.其电子提取的氟氢原子使其成为制药,农用化学品和特殊材料制作过程中的宝贵中间体.三氟甲基组具有更大的稳定性和亲性,可以提高衍生化合物的生物利用率. 4,4,4,4-三氟丁烷在核循环添加反应和氟化乙烷循环建筑块方面特别有用.其高纯度和一贯性能使得它成为需要精确氟化的研究和工业应用的可靠选择.

结构式图片

相似化合物

406-93-9 461-18-7 371-26-6

欧盟法规

ECHA物质C&L通报

上下游产品

4,4,4-trifluorobutanol 3,3,3-trifluoropropyl magnesium chloride orthoformic acid triethyl ester 1,1,1-trifluoropropylene 4,4,4-trifluorobutanol 2-phenyl-4-(4,4,4-trifluorobutylidene)-5-oxazolone 2-phenyl-4-(4,4,4-trifluorobutylidene)-5-oxazolone 2-amino-5,5,5-trifluoropentanoic acid

合成工艺路线路线简述

    4,4,4-三氟丁酸乙酯置于盐酸体系中,用 二氯甲烷 作为反应溶剂,化学反应生成 4,4,4-三氟丁醛
    参考文献:Fluoro-And Trifluoroalkyl-Containing Heterocyclic Sulfonamide Inhibitors Of Beta Amyloid Production And Derivatives Thereof
    标题:Fluoro-And Trifluoroalkyl-Containing Heterocyclic Sulfonamide Inhibitors Of Beta Amyloid Production And Derivatives Thereof
    摘要:提供了具有式(I)的化合物,其中t为cho,Con或c(Oh)R1R2;r1和r2为氢,可选择取代的较低烷基,Cf3,可选择取代的烯烃或可选择取代的炔烃;r3为氢或可选择取代的较低烷基;r4为(Cf3)N烷基,(Cf3)N(取代烷基),(Cf3)N烷基苯基,(Cf3)N烷基(取代苯基)或(F)N环烷基;n=1-3;r5为氢,卤素,Cf3,与y融合的双烯烃(当y为c时),或与y融合的取代双烯烃(当y为c时);w,Y和z为c,Cr6或n,其中至少有一个为c;r6为氢,卤素或可选择取代的较低烷基;x为o,S,So2或nr7;r7为氢,可选择取代的较低烷基,可选择取代的苄基或可选择取代的苯基;r8为较低烷基,Cf3或可选择取代的苯基.还描述了制备和使用这些化合物来抑制β淀粉样蛋白的产生,以及治疗阿尔茨海默病和唐氏综合征的方法.

    海关参考信息

    专利信息


    专利号:WO-0120995-A9
    优先权日:1999-09-23
    标题:Compounds directed against pilus biogenesis and activity in pathogenic bacteria; methods and compositions for synthesis thereof
    发明人:KIHLBERG JAN; LARSSON ANDREAS; SVENSSON ANETTE; FEX TOMAS; HULTGREN SCOTT J; PINKNER JERRY
    权利人:UNIV WASHINGTON; KIHLBERG JAN; LARSSON ANDREAS; SVENSSON ANETTE; FEX TOMAS; HULTGREN SCOTT J; PINKNER JERRY
    摘要:Many Gram-negative pathogens assemble adhesive structures on their surfaces that allow them to colonize host tissues and cause disease. Novel compositions which inhibit or prevent the formation of a pilus chaperone-subunit complex are disclosed. Interfering with the function of the pili chaperone negatively affects the chaperone/usher pathway which is one molecular mechanism by which Gram-negative bacteria assemble adhesive pili structures and thus prevent or inhibit pilus assembly. Also provided are methods for the treatment or prevention of diseases caused by tissue-adhering pilus-forming bacteria by inhibiting the function of pilus chaperones. Also provided are pharmaceutical preparations capable of inhibiting or preventing the formation of a pilus chaperone-subunit complex. Also provided are methods of synthesizing the N-substituted amino acid compounds and compounds useful for the synthesis thereof. In particular, novel fluorinated linker compounds and methods of synthesis are provided. Methods for using the fluorinated linker compounds in methods of solid-phase synthesis of the N-substituted amino acid compounds are also disclosed.

    专利号:US-2003096374-A1
    优先权日:1999-01-27
    标题:Synthesis of oligoketides

    专利号:WO-2022213975-A1
    优先权日:2021-04-08
    标题:Compounds targeting y220c mutant of p53
    发明人:LI SUJING; LI AMIN; ZHENG QIAN; Dang Chaojie; FAN XINRUI; LONG WEI; WANG YANPING
    权利人:JACOBIO PHARMACEUTICALS CO LTD
    摘要:Provided are compounds of formula (I) which can bind to p53 mutant and restore its ability to bind DNA and activate downstream effects involved in tumor suppression. Also provided are the synthesis processes and use of the compounds.

    专利号:WO-0044717-A2
    优先权日:1999-01-27
    标 题 :Synthesis of oligoketides

    专利号:WO-0044717-A3
    优先权日:1999-01-27
    标题 :Synthesis of oligoketides

    专利号:US-7022825-B2
    优先权日:1999-01-27
    标 题 :Polyketides and antibiotics
    发明人:ASHLEY GARY; CHAN-KAI ISAAC C; BURLINGAME MARK A
    权利人:KOSAN BIOSCIENCES INC
    摘要:Facile methods for preparing diketide and triketide thioesters are disclosed. The resulting thioesters may be used as intermediates in the synthesis of desired polyketides, and may contain functional groups which ultimately reside in side chains on the resulting polyketide and thus can be used further to manipulate the polyketide so as form derivatives. The polyketides produced may also be tailored by glycosylation, hydroxylation and the like. New polyketides and their derivatives and tailored forms are thereby produced.
    海门瑞一医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ruiyitech.cn
    企业联系电话:021-54718086👤
    📞海门瑞一医药科技有限公司 ⚠️参考联系方式
    联系人:余小姐
    电话:021-54718086

    传真:021-54711707
    邮箱:sales5@ruiyitech.com
    通信地址: 江苏海门大庆路19号
    邮编: 226100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏海门大庆路19号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Malacria, M.; Aubert, C.; Renaud, J.-L., Science of Synthesis, (2001) 1, 496.
    摘要:Breit, B., Science of Synthesis, (2007) 25, 313.
    摘要:Breit, B., Science of Synthesis, (2007) 25, 283.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知